dChan
Anonymous ID: f0ee76 Oct. 20, 2020, 9:54 a.m. No.11171626   🗄️.is đź”—kun   >>1822 >>2613 >>2714

CRICK22 USAFSOC C-32B dropped off scope from a Ft. Bragg departure over W. VA and appeared again heading sw

TERRA97 USAFSOC C-32B out from another quick ground stop (2 already) at JBA-looks like it is heading back to McGuire AFB, NJ from origin earlier

Anonymous ID: f0ee76 Oct. 20, 2020, 10:12 a.m. No.11171878   🗄️.is đź”—kun   >>2162 >>2613 >>2714

Array Technologies sold by Brookfield Cap. Mgmt and Oaktree Cap. Mgmt: $1.04b-Oct 19

 

part of an IPO

Array Technologies, Inc. Announces Closing of Initial Public Offering

ALBUQUERQUE, N.M., Oct. 19, 2020 (GLOBE NEWSWIRE) – Array Technologies, Inc. (the “Company”) today announced the closing of its upsized initial public offering of 54,625,000 shares of common stock. The offering consisted of 7,000,000 shares of common stock issued and sold by the Company and 47,625,000 shares of common stock sold by a parent entity of the Company controlled by Oaktree Capital (the “Selling Stockholder”), which included an additional 7,125,000 shares of the Company’s common stock following the exercise in full of the underwriters’ option to purchase additional shares of the Company’s common stock from the Selling Stockholder, in each case at an initial public offering price of $22.00 per share. The Company did not receive any of the proceeds from the sale of shares offered by the Selling Stockholder. The common stock began trading on the Nasdaq Global Market under the symbol “ARRY” on October 15, 2020.

 

Goldman Sachs & Co. LLC and J.P. Morgan acted as joint book-running managers and representatives of the underwriters for the offering. Guggenheim Securities and Morgan Stanley acted as joint book-running managers and Credit Suisse, Barclays and UBS Investment Bank acted as book-runners.

Cowen, Oppenheimer & Co. Inc., MUFG and Nomura acted as co-managers.

https://www.marketscreener.com/quote/stock/ARRAY-BIOPHARMA-INC-8433/news/Array-Technologies-Inc-Announces-Closing-of-Initial-Public-Offering-31568594/

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC). Its binimetinib and encorafenib are in Phase III trials in advanced cancer patients, including the COLUMBUS trial studying encorafenib in combination with binimetinib in patients with BRAF-mutant melanoma and has initiated BEACON CRC trial to study encorafenib in combination with binimetinib and cetuximab in patients with BRAF V600E-mutant colorectal cancer (BRAFm CRC). Its selumetinib is a mitogen-activated protein kinase (MEK) inhibitor for cancer, which is in Phase III trial. Its advanced clinical-stage drugs include Filanesib, ARRY-797, ASC08/Danoprevir, Ipatasertib/GDC-0068, Motolimod/VTX-2337, LOXO-101, ONT-380/ARRY-380, GDC-0575, GDC-0994 and ARRY-382. Number of employees : 298 people.

https://www.marketscreener.com/quote/stock/ARRAY-BIOPHARMA-INC-8433/company/

 

Brookfield Asset Management specializes in asset management, primarily in the real estate and energy sectors. Revenues breaks down by activity as follows:

  • real estate services (58%);

  • residential development (16.2%);

  • real estate property management (16.2%): offices, commercial properties, industrial sites, hotels, etc.;

  • infrastructure improvement services (9.1%);

  • energy asset management (6.6%): operating 217 hydroelectric plants at the end of 2017 (total installed capacity of 7,000 MW) and 38 wind farms located mainly in North America;

  • fund management (3.5%): pension funds, venture capital, investment funds, etc.;

  • other (0.8%).

At the end of 2017, the group was managing assets with a total value of EUR188.3 billion. Revenues are distributed geographically as follows: Canada (14.4%), the United States (20.3%), the united Kingdom (37%), Australia (10.8%), Brazil (7.9%), Colombia (2.4%) and other (7.2%). Number of employees : 151 900 people.

Brookfield Asset Management Inc. is an alternative asset management company focusing on real estate, renewable power, infrastructure and private equity. The company's headquarters are located in Toronto, and it also has corporate offices in New York City, London, Rio de Janeiro and Sydney. The company was founded in 1899, as the SĂŁo Paulo Tramway, Light and Power Company by William Mackenzie and Frederick Stark Pearson. Operating as in construction and management of electricity and transport infrastructure in Brazil.

moar here

https://en.wikipedia.org/wiki/Brookfield_Asset_Management

https://www.marketscreener.com/quote/stock/BROOKFIELD-ASSET-MANAGEME-1409206/company/

https://www.finviz.com/insidertrading.ashx?oc=1827785&tc=7&b=2